Throughout the month of May, the Lupus Foundation of America is encouraging people living with lupus, friends, family members and partners to be loud and use their voices more than ever before to Make ...
Today, Merck KGaA, Darmstadt, Germany, whose U.S. healthcare arm is EMD Serono, announced that the first trial participant ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
People living with lupus develop strengths that are unique to this journey, and it’s time we paused to honor and celebrate the strengths of a lupus warrior.
National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...
Sjogren’s disease is a chronic autoimmune disorder in which the moisture-producing glands do not function correctly; Sjogren's can also affect internal organs. Sjogren’s disease is a relatively common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results